These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 23339052)

  • 1. Synthesis of long-circulating, backbone degradable HPMA copolymer-doxorubicin conjugates and evaluation of molecular-weight-dependent antitumor efficacy.
    Pan H; Sima M; Yang J; Kopeček J
    Macromol Biosci; 2013 Feb; 13(2):155-60. PubMed ID: 23339052
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Backbone degradable multiblock N-(2-hydroxypropyl)methacrylamide copolymer conjugates via reversible addition-fragmentation chain transfer polymerization and thiol-ene coupling reaction.
    Pan H; Yang J; Kopecková P; Kopecek J
    Biomacromolecules; 2011 Jan; 12(1):247-52. PubMed ID: 21158387
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HPMA copolymer-doxorubicin-gadolinium conjugates: synthesis, characterization, and in vitro evaluation.
    Zarabi B; Nan A; Zhuo J; Gullapalli R; Ghandehari H
    Macromol Biosci; 2008 Aug; 8(8):741-8. PubMed ID: 18484565
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preclinical evaluation of linear HPMA-doxorubicin conjugates with pH-sensitive drug release: efficacy, safety, and immunomodulating activity in murine model.
    Sirova M; Mrkvan T; Etrych T; Chytil P; Rossmann P; Ibrahimova M; Kovar L; Ulbrich K; Rihova B
    Pharm Res; 2010 Jan; 27(1):200-8. PubMed ID: 19894105
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pronounced Cellular Uptake of Pirarubicin versus That of Other Anthracyclines: Comparison of HPMA Copolymer Conjugates of Pirarubicin and Doxorubicin.
    Nakamura H; Koziolová E; Chytil P; Tsukigawa K; Fang J; Haratake M; Ulbrich K; Etrych T; Maeda H
    Mol Pharm; 2016 Dec; 13(12):4106-4115. PubMed ID: 27934482
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Backbone Degradable N-(2-Hydroxypropyl)methacrylamide Copolymer Conjugates with Gemcitabine and Paclitaxel: Impact of Molecular Weight on Activity toward Human Ovarian Carcinoma Xenografts.
    Yang J; Zhang R; Pan H; Li Y; Fang Y; Zhang L; Kopeček J
    Mol Pharm; 2017 May; 14(5):1384-1394. PubMed ID: 28094954
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New HPMA copolymer-based drug carriers with covalently bound hydrophobic substituents for solid tumour targeting.
    Chytil P; Etrych T; Konák C; Sírová M; Mrkvan T; Boucek J; Ríhová B; Ulbrich K
    J Control Release; 2008 Apr; 127(2):121-30. PubMed ID: 18304673
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Polymer conjugates of doxorubicin bound through an amide and hydrazone bond: Impact of the carrier structure onto synergistic action in the treatment of solid tumours.
    Etrych T; Subr V; Laga R; Ríhová B; Ulbrich K
    Eur J Pharm Sci; 2014 Jul; 58():1-12. PubMed ID: 24632485
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Design of a multivalent galactoside ligand for selective targeting of HPMA copolymer-doxorubicin conjugates to human colon cancer cells.
    David A; Kopecková P; Minko T; Rubinstein A; Kopecek J
    Eur J Cancer; 2004 Jan; 40(1):148-57. PubMed ID: 14687799
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Star-shaped immunoglobulin-containing HPMA-based conjugates with doxorubicin for cancer therapy.
    Etrych T; Mrkvan T; Ríhová B; Ulbrich K
    J Control Release; 2007 Sep; 122(1):31-8. PubMed ID: 17631976
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Polymer conjugates of the highly potent cytostatic drug 2-pyrrolinodoxorubicin.
    Studenovsky M; Ulbrich K; Ibrahimova M; Rihova B
    Eur J Pharm Sci; 2011 Jan; 42(1-2):156-63. PubMed ID: 21075206
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and evaluation of a backbone biodegradable multiblock HPMA copolymer nanocarrier for the systemic delivery of paclitaxel.
    Zhang R; Luo K; Yang J; Sima M; Sun Y; Janát-Amsbury MM; Kopeček J
    J Control Release; 2013 Feb; 166(1):66-74. PubMed ID: 23262201
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biodegradable multiblock poly(N-2-hydroxypropyl)methacrylamide gemcitabine and paclitaxel conjugates for ovarian cancer cell combination treatment.
    Larson N; Yang J; Ray A; Cheney DL; Ghandehari H; Kopeček J
    Int J Pharm; 2013 Sep; 454(1):435-43. PubMed ID: 23827653
    [TBL] [Abstract][Full Text] [Related]  

  • 14. FRET-trackable biodegradable HPMA copolymer-epirubicin conjugates for ovarian carcinoma therapy.
    Yang J; Zhang R; Radford DC; Kopeček J
    J Control Release; 2015 Nov; 218():36-44. PubMed ID: 26410808
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targetable HPMA copolymer-adriamycin conjugates. Recognition, internalization, and subcellular fate.
    Omelyanenko V; Kopecková P; Gentry C; Kopecek J
    J Control Release; 1998 Apr; 53(1-3):25-37. PubMed ID: 9741911
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Potential of Poly[N-(2-hydroxypropyl)methacrylamide] via Reversible Addition-Fragmentation Chain Transfer Polymerization as Safe Nanocarrier.
    Zhang Y; Guo C; Li S; Luo K; Hu J; Gu Z
    J Nanosci Nanotechnol; 2016 Jun; 16(6):5746-54. PubMed ID: 27427626
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Conjugates of doxorubicin with graft HPMA copolymers for passive tumor targeting.
    Etrych T; Chytil P; Mrkvan T; Sírová M; Ríhová B; Ulbrich K
    J Control Release; 2008 Dec; 132(3):184-92. PubMed ID: 18534705
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biodistribution and antitumour efficacy of long-circulating N-(2-hydroxypropyl)methacrylamide copolymer-doxorubicin conjugates in nude mice.
    Shiah JG; Dvorák M; Kopecková P; Sun Y; Peterson CM; Kopecek J
    Eur J Cancer; 2001 Jan; 37(1):131-9. PubMed ID: 11165140
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Binding and cytotoxicity of HPMA copolymer conjugates to lymphocytes mediated by receptor-binding epitopes.
    Tang A; Kopeiková P; Kopeckevá J
    Pharm Res; 2003 Mar; 20(3):360-7. PubMed ID: 12669954
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The structure-dependent toxicity, pharmacokinetics and anti-tumour activity of HPMA copolymer conjugates in the treatment of solid tumours and leukaemia.
    Tomalova B; Sirova M; Rossmann P; Pola R; Strohalm J; Chytil P; Cerny V; Tomala J; Kabesova M; Rihova B; Ulbrich K; Etrych T; Kovar M
    J Control Release; 2016 Feb; 223():1-10. PubMed ID: 26708020
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.